Asahi Beverages has lost a bid for preliminary discovery to consider whether it should bring misleading and deceptive conduct claims against a unit of Retail Food Group, owner of the popular Gloria Jeans Coffee and Donut King franchises.
The High Court has granted an appeal to a Norton Rose Fulbright-represented man who claimed more than 900g of marijuana found at his house was for personal use, repealing his conviction for drug possession after new evidence emerged that may have changed the course of his trial in 2013.
A Federal Court judge that threw out a consumer class action against MyBudget has denied the budget management company’s bid for costs, finding the case was brought in the public interest.
A sex discrimination lawsuit against advertising giant M&C Saatchi by a contract employee who claimed he was fired after requesting flexible hours to take care of his children has been resolved.
A former employment partner at Norton Rose Fulbright may ask a Federal Court judge to recuse himself from a long-running dispute with the law firm, saying the judge’s previous comments had triggered a “reasonable apprehension” of bias.
A unit of Fortescue Metals Group has won its bid for emails between Squire Patton Boggs and a unit of electricity provider TransAlta Energy relating to a disputed power purchase agreement, saying privilege was waived when the emails were forwarded to a third party.
A judge has signed off on a $3.5 million settlement in a case brought by the consumer watchdog against Equifax Australia, with the credit reporting company admitting it made misleading claims in selling paid credit packages to vulnerable consumers.
MyBudget has successfully fought off a class action brought by consumers who claimed the budget management firm violated consumer law by holding onto interest earned on their personal budgeting accounts.
Europcar has fired back at the consumer watchdog in an enforcement action alleging the car rental company applied excessive payment surcharges on debit and credit card purchases, saying it always intended to refund overcharged customers, and did.
The defendants in a shareholder class action over QRxPharma’s alleged failure to disclose problems with regulatory approval for its painkiller Moxduo have won access to information on class members’ financial brokers.